The cause of rare diseases is increasingly being detected through genome sequencing, which involves reading the entire human DNA by first breaking it into small pieces-short reads.
Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness
A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called
May 8, 2024